These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9541985)

  • 21. Laboratory trials with inactivated vaccines against Escherichia coli (O78 K80) infection in fowls.
    Deb JR; Harry EG
    Res Vet Sci; 1976 Mar; 20(2):131-8. PubMed ID: 772771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A vaccine against avian colibacillosis based on ultrasonic inactivation of Escherichia coli.
    Melamed D; Leitner G; Heller ED
    Avian Dis; 1991; 35(1):17-22. PubMed ID: 2029251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in vaccination against avian pathogenic Escherichia coli respiratory disease: potentials and limitations.
    Ghunaim H; Abu-Madi MA; Kariyawasam S
    Vet Microbiol; 2014 Aug; 172(1-2):13-22. PubMed ID: 24878325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A carAB mutant of avian pathogenic Escherichia coli serogroup O2 is attenuated and effective as a live oral vaccine against colibacillosis in turkeys.
    Kwaga JK; Allan BJ; van der Hurk JV; Seida H; Potter AA
    Infect Immun; 1994 Sep; 62(9):3766-72. PubMed ID: 8063392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity in chickens with orally administered recombinant chicken-borne Lactobacillus saerimneri expressing FimA and OmpC antigen of O78 avian pathogenic Escherichia coli.
    Ma ST; Ding GJ; Huang XW; Wang ZW; Wang L; Yu ML; Shi W; Jiang YP; Tang LJ; Xu YG; Li YJ
    J Med Microbiol; 2018 Mar; 67(3):441-451. PubMed ID: 29458539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a modified bacterial ghost lysis system for the construction of an inactivated avian pathogenic Escherichia coli vaccine candidate.
    Hu J; Zuo J; Chen Z; Fu L; Lv X; Hu S; Shi X; Jing Y; Wang Y; Wang Z; Mi R; Huang Y; Liu D; Qi K; Han X
    Vet Microbiol; 2019 Feb; 229():48-58. PubMed ID: 30642598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infectious bronchitis immunity: its study in chickens experimentally infected with mixtures of infectious bronchitis virus and Escherichia coli.
    Cook JK; Smith HW; Huggins MB
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1427-34. PubMed ID: 3014052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, immunogenicity, and efficacy of two Escherichia coli cya crp mutants as vaccines for broilers.
    Peighambari SM; Hunter DB; Shewen PE; Gyles CL
    Avian Dis; 2002; 46(2):287-97. PubMed ID: 12061637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Colibacillosis in poultry (author's transl)].
    Goren E
    Tijdschr Diergeneeskd; 1980 Apr; 105(7):290-4. PubMed ID: 6990550
    [No Abstract]   [Full Text] [Related]  

  • 30. Laboratory trials with inactivated vaccines against Escherichia coli (O2:K1) infection in fowls.
    Deb JR; Harry EG
    Res Vet Sci; 1978 May; 24(3):308-13. PubMed ID: 353924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological and immunological characterization of pili of Escherichia coli serotypes O1, O2, and O78 pathogenic to poultry.
    Suwanichkul A; Panigrahy B
    Avian Dis; 1986; 30(4):781-7. PubMed ID: 2880578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of an autogenous Escherichia coli vaccine in broiler breeders.
    Li L; Thøfner I; Christensen JP; Ronco T; Pedersen K; Olsen RH
    Avian Pathol; 2017 Jun; 46(3):300-308. PubMed ID: 27982712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Method of administration affects the ability of bacteriophage to prevent colibacillosis in 1-day-old broiler chickens.
    Huff WE; Huff GR; Rath NC; Donoghue AM
    Poult Sci; 2013 Apr; 92(4):930-4. PubMed ID: 23472016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitory effects of α-cyperone on adherence and invasion of avian pathogenic Escherichia coli O78 to chicken type II pneumocytes.
    Zhang LY; Lv S; Wu SC; Guo X; Xia F; Hu XR; Song Z; Zhang C; Qin QQ; Fu BD; Yi PF; Shen HQ; Wei XB
    Vet Immunol Immunopathol; 2014 May; 159(1-2):50-7. PubMed ID: 24629766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2:K1 serotype.
    Hoseini Shahidi R; Hashemi Tabar G; Bassami MR; Jamshidi A; Dehghani H
    Res Vet Sci; 2019 Aug; 125():153-161. PubMed ID: 31228739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune responses to oral vaccination with Salmonella-delivered avian pathogenic Escherichia coli antigens and protective efficacy against colibacillosis.
    Lee JH; Chaudhari AA; Oh IG; Eo SK; Park SY; Jawale CV
    Can J Vet Res; 2015 Jul; 79(3):229-34. PubMed ID: 26130856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of an Escherichia coli J5 mastitis vaccine in an experimental challenge trial.
    Hogan JS; Weiss WP; Todhunter DA; Smith KL; Schoenberger PS
    J Dairy Sci; 1992 Feb; 75(2):415-22. PubMed ID: 1560136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A biologically conjugated polysaccharide vaccine delivered by attenuated Salmonella Typhimurium provides protection against challenge of avian pathogenic Escherichia coli O1 infection.
    Han Y; Liu Q; Yi J; Liang K; Wei Y; Kong Q
    Pathog Dis; 2017 Nov; 75(8):. PubMed ID: 28911037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of chicken resistance against Escherichia coli infection by oral administration of Bifidobacterium thermophilum preparations.
    Kobayashi C; Yokoyama H; Nguyen SV; Hashi T; Kuroki M; Kodama Y
    Avian Dis; 2002; 46(3):542-6. PubMed ID: 12243516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avian pathogenic Escherichia coli (APEC).
    Dho-Moulin M; Fairbrother JM
    Vet Res; 1999; 30(2-3):299-316. PubMed ID: 10367360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.